Michael R. Freund

Hebrew University of Jerusalem

Papers

2

Total Citations

80

H-Index

2

About

Dr. Michael R. Freund is a surgical oncologist whose research focuses on optimizing treatment strategies for rectal cancer, with a particular emphasis on minimally invasive surgical techniques and population-level outcomes. His major contributions include a landmark 2022 study analyzing trends in rectal adenocarcinoma management across 16 years of US data, which documented significant shifts in treatment patterns and patient outcomes (65 citations). Dr. Freund has also advanced the debate on surgical approaches for complex cases, notably through a propensity score-matched analysis comparing laparoscopic versus robotic-assisted resection for T4 rectal cancer (15 citations). His work leverages large national databases to provide evidence-based insights that directly inform clinical decision-making for challenging oncologic scenarios. By examining both broad epidemiological trends and specific technical comparisons, Dr. Freund’s research bridges the gap between population health and operative practice, offering valuable guidance for surgeons managing advanced rectal malignancies.

Research Focus

Key Achievements

2
H-Index
2
Papers
80
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019
65 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hebrew University of Jerusalem

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago